Armando E. Giuliano

Surgical Oncology
310 N San Vicente Blvd Bldg 3RD Fl 3
West Hollywood, CA 90048

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 194 publications

Beyond ADCs: Antibody-encapsulated drug for targeted cancer therapy.

Beyond ADCs: Antibody-encapsulated drug for targeted cancer therapy.

Journal: Cell investigation
Published: August 25, 2026

ASO Visual Abstract: Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB)-De-escalation of Axillary Surgery and Increased Use of Radiation.

ASO Visual Abstract: Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB)-De-escalation of Axillary Surgery and Increased Use of Radiation.

Journal: Annals of surgical oncology
Published: July 02, 2026

ASO Author Reflections: Evolving Axillary Management in Young Women with Breast Cancer.

ASO Author Reflections: Evolving Axillary Management in Young Women with Breast Cancer.

Journal: Annals of surgical oncology
Published: June 11, 2026

Core Needle Biopsy and Preoperative Risk Factors as Predictors of Upstaging Atypical Ductal Hyperplasia on Surgical Excision.

Core Needle Biopsy and Preoperative Risk Factors as Predictors of Upstaging Atypical Ductal Hyperplasia on Surgical Excision.

Journal: The American surgeon
Published: May 08, 2026

Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB): De-escalation of Axillary Surgery and Increased Use of Radiation.

Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB): De-escalation of Axillary Surgery and Increased Use of Radiation.

Journal: Annals of surgical oncology
Published: February 20, 2026

Computer-aided image analysis for PD-L1 assessment in canine urothelial carcinoma.

Computer-aided image analysis for PD-L1 assessment in canine urothelial carcinoma.

Journal: Veterinary journal (London, England : 1997)
Published: February 08, 2026

Developing an antibody drug encapsulation nanoagent targeting HER2 for cancer treatment.

Developing an antibody drug encapsulation nanoagent targeting HER2 for cancer treatment.

Journal: Journal of translational medicine
Published: June 11, 2025

Caregiver burden in owners of dogs and cats undergoing anticancer therapy in a referral hospital in Hong Kong.

Caregiver burden in owners of dogs and cats undergoing anticancer therapy in a referral hospital in Hong Kong.

Journal: The Journal of small animal practice
Published: May 28, 2025

Tumor immune microenvironment and immune phenotypes in PD-L1-tested canine urothelial carcinoma.

Tumor immune microenvironment and immune phenotypes in PD-L1-tested canine urothelial carcinoma.

Journal: BMC veterinary research
Published: May 12, 2025

ASO Author Reflections: Advances in Axillary Management for Breast Cancer After Neoadjuvant Chemotherapy.

ASO Author Reflections: Advances in Axillary Management for Breast Cancer After Neoadjuvant Chemotherapy.

Journal: Annals of surgical oncology
Published: March 24, 2025

Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial.

Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial.

Journal: JAMA oncology
Published: December 12, 2024

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.

Journal: JAMA
Published: December 12, 2024
Showing 1-12 of 194

Last Updated: 09/26/2026